310. State Department of Health Requirements for Reporting of Antibiotic Resistant Infections by Physicians
Session: Poster Abstract Session: HAI: Epidemiology
Thursday, October 8, 2015
Room: Poster Hall
Posters
  • ID Week 2015 Notifiable Conditions Poster.pdf (609.8 kB)
  • Background: Due to the high burden of antibiotic resistant infections, several states have enacted laws mandating data submission and public reporting of antibiotic resistant infections in healthcare settings. In addition to these types of reporting mandates, state departments of health (DOH) have the authority to require reporting of diseases by healthcare providers. The objective of this study was to describe the extent to which state DOHs require clinician reporting of antibiotic resistant infections and to examine changes over a two year period.

    Methods: In spring 2013, we abstracted data from the reportable conditions lists for all 50 states as presented on state DOH websites. The search was updated in May 2015 and state requirements between the two time periods were compared.

    Results: The majority of states (n=46, 92%) require clinician reporting of at least one antibiotic resistant infection (See Table) with vancomycin-intermediately susceptible and/or vancomycin-resistant Staphylococcus aureus (VISA/VRSA) as the most frequently reportable infection (n=40). Less than a quarter required reporting of methicillin-resistant S. aureus (MRSA, n=11), multi-drug resistant gram negative bacteria (MDR GNB, n=8) and vancomycin-resistant enterococci (VRE, n = 8). In the two year period from April 2013 to May 2015, 5 states removed an antibiotic resistant infection from their reporting requirements (2 MRSA, 2 VRE, 1 VISA/VRSA), whereas 11 states added a reporting requirement (8 MDR GNB, 3 VISA/VRSA, 1 C. difficile).

    Conclusion:  Required reporting of antibiotic resistant infections varies substantially by state. Changes in reporting requirements over a two-year period suggest flexibility in the way that state DOHs can respond to their local surveillance needs and emerging threats.

     

    Table. State Department of Health Reporting Requirements for Physicians

    Type of infection

    N (%)

    States

    Clostridium difficile

    2 (4)

    NM, TN

    MDR GNB

    8 (16)

    AK, DE, ND, OR, SD, TN, TX, UT

    MRSA

    11 (22)

    CT, DE, IL, LA, ME, MI, MO, ND, SD, TN, WY

    VRE

    8 (16)

    DE, HI, LA, MO, MS, NH, NC, WY

    VISA/VRSA

    40 (80)

    All except CA, CO, ID, KS, KY, MA, MT, NM, OR, VT

    VR S. epidermidis

    2 (4)

    AZ, CT

    Resistant streptococcal disease

    5 (10)

    KS, KY, MO, NV, PA

    Monika Pogorzelska-Maziarz, PhD, MPH1, Eileen J. Carter, PhD, RN2, Mary Lou Manning, PhD, CRNP, CIC, FAAN1 and Elaine Larson, RN, PhD, FAAN, CIC, FIDSA, FSHEA3, (1)Thomas Jefferson University, College of Nursing, Philadelphia, PA, (2)Office of Evidence-Based Practice, Research and Innovation, NewYork-Presbyterian Hospital, New York, NY, (3)School of Nursing, Columbia University Medical Center, New York, NY

    Disclosures:

    M. Pogorzelska-Maziarz, None

    E. J. Carter, None

    M. L. Manning, None

    E. Larson, None

    See more of: HAI: Epidemiology
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.